Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Cipla
Julphar
Federal Trade Commission
US Department of Justice
Argus Health
Baxter
Novartis
UBS

Generated: October 20, 2017

DrugPatentWatch Database Preview

LACOSAMIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Lacosamide, and when can generic versions of Lacosamide launch?

Lacosamide is a drug marketed by Msn Labs Pvt Ltd, Mylan Pharms Inc, Sun Pharma Global, Amneal Pharms, Actavis Labs Fl Inc, Alembic Pharms Ltd, and Aurobindo Pharma Ltd. and is included in eight NDAs.

The generic ingredient in LACOSAMIDE is lacosamide. There are twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the lacosamide profile page.

Summary for Tradename: LACOSAMIDE

US Patents:0
Applicants:7
NDAs:8
Suppliers / Packagers: see list3
Bulk Api Vendors: see list60
Clinical Trials: see list79
Patent Applications: see list585
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LACOSAMIDE at DailyMed

Pharmacology for Tradename: LACOSAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
LACOSAMIDE
lacosamide
TABLET;ORAL204994-003Apr 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
LACOSAMIDE
lacosamide
TABLET;ORAL204994-004Apr 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Msn Labs Pvt Ltd
LACOSAMIDE
lacosamide
TABLET;ORAL204921-001Apr 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
LACOSAMIDE
lacosamide
TABLET;ORAL204857-001Sep 9, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alembic Pharms Ltd
LACOSAMIDE
lacosamide
TABLET;ORAL204974-003Apr 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
LACOSAMIDE
lacosamide
TABLET;ORAL205026-003Apr 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Msn Labs Pvt Ltd
LACOSAMIDE
lacosamide
TABLET;ORAL204921-004Apr 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
LACOSAMIDE
lacosamide
TABLET;ORAL205031-004Apr 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
LACOSAMIDE
lacosamide
TABLET;ORAL204857-003Sep 9, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
LACOSAMIDE
lacosamide
TABLET;ORAL205026-004Apr 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Dow
Johnson and Johnson
Novartis
US Army
US Department of Justice
Fuji
Citi
Julphar
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot